Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Jason Genin

Sports Medicine Lorain, OH Doctor of Osteopathy

NPI 1548466493 CMS profile 70202

5800 Cooper Foster Park Rd W, Lorain, OH 44053

Open in the dashboard

General payments

$115,200

121 records reported · program years 2019–2025

Research payments

$10,000

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$24,254 paid to institutions, not to them · program year 2024

Through program year 2025, Jason Genin of Lorain, OH is reported in the CMS Open Payments database as having received $115,200 across 121 general payments and $10,000 in research payments paid to them. Separately, studies naming them as principal investigator received $24,254 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Sports Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $15,841 18
2024 General $5,746 15
2023 General $13,457 17
2022 General $9,508 9
2021 General $13,969 12
2020 General $26,909 24
2019 General $29,771 26
2019 Research $10,000 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jason Genin
  • Sports Medicine median
  • Middle half of Sports Medicine
  • National median

In program year 2025, general payments to Jason Genin were reported at $15,841. Among 1,257 Sports Medicine profiles paid that year, the median was $114 and the middle half received between $39 and $293.

Show as a table
Year Jason Genin Sports Medicine median Middle half National median
2019 $29,771 $119 $35–$362 $163
2020 $26,909 $77 $24–$275 $114
2021 $13,969 $104 $28–$340 $132
2022 $9,508 $94 $31–$272 $149
2023 $13,457 $91 $34–$271 $160
2024 $5,746 $126 $38–$294 $164
2025 $15,841 $114 $39–$293 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. HydroCision, Inc. $88,794 70 payments
  2. CyMedica Orthopedics, Inc. $23,629 5 payments
  3. Djo, LLC $1,775 6 payments
  4. Flexion Therapeutics, Inc. $585 19 payments
  5. Bioventus LLC $213 9 payments
  6. Horizon Therapeutics plc $76 5 payments
  7. Kerecis Limited $30 1 payment
  8. Ferring Pharmaceuticals Inc. $26 2 payments
  9. Trice Medical, Inc. $23 1 payment
  10. Smith+Nephew, Inc. $22 1 payment
  11. Other $27 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $110,390 44 payments
  2. Food and Beverage $3,228 75 payments
  3. Travel and Lodging $1,581 2 payments
Products named General payments · program years 2019–2025
  1. TENJET Orthopedic & Spine $44,272 47 payments
  2. TenJet Orthopedic & Spine $30,596 14 payments
  3. AlloJet $23,596 12 payments
  4. SpineJet $23,596 12 payments
  5. TenJet Orthopedic & Spine $13,926 9 payments
  6. DVT VENAPRO $1,470 1 payment
  7. Zilretta $585 19 payments
  8. DUROLANE Orthopedicsorthopedic Surgery $137 6 payments
  9. DUEXIS $63 4 payments
  10. Durolane Orthopedics/Orthopedic Surgery $55 2 payments
  11. Other $285 14 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Skye Orthobiologics LLC $10,000 1 payment

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

135

Median for Sports Medicine: 144

Drug cost

$2,661

Median for Sports Medicine: $1,027

Branded share of claims

11.9%

Median for Sports Medicine: 0%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Diclofenac Sodium-Misoprostol Diclofenac Sodium/Misoprostol Brand 16 $1,148
Celecoxib Generic 29 $872
Diclofenac Sodium Generic 50 $482
Methylprednisolone Generic 19 $112
Prednisone Generic 21 $47

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,691 Part D prescribers listed as Sports Medicine; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 26 billing codes

Paid by Medicare

$30,778

Medicare's payments for the services billed

Medicare patients

245

Average age 71

Services billed

609

139 women, 106 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 58%
Diabetes 19%
Ischemic heart disease 18%
Depression 16%
Cancer 14%
Osteoporosis 13%
Chronic kidney disease 11%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

122 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Sports Medicine in Ohio

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record